Parthenolide Modulates Immune Response in Cells from C57BL/6 Mice Induced with Experimental Autoimmune Encephalomyelitis

• Autor(a) principal: Aleixo de Carvalho, Lara Soares
• Data de Publicação: 2017
• Outros Autores: Almeida Fontes, Livia Beatriz, Gazolla, Matheus Coutinho, Dias, Debora dos Santos, Juliano, Maria Aparecida [UNIFESP], Macedo, Gilson Costa, do Amaral Correa, Jose Otavio, Da Silva Filho, Ademar A.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNIFESP
• Texto Completo: http://dx.doi.org/10.1055/s-0042-122783; https://repositorio.unifesp.br/handle/11600/54562
• topic: parthenolide; Tanacetum parthenium; Asteracrae; multiple sclerosis; experimental autoimmune encephalomyelitis; IL-17

Multiple sclerosis is a chronic inflammatory and autoimmune disease of the central nervous system that affects more than 2.5 million people worldwide. Experimental autoimmune encephalomyelitis is a murine autoimmune disease used to study multiple sclerosis. Parthenolide, a natural sesguiterpene lactone found in Tanocetum parthenium L., is known for its strong anti-inflammatory activity. Herein, we have investigated the in vitro irnmunomodulatory effects of parthenolide on cytokine production and nitric oxide in cultured cells from myelin oligodendrocyte glycoprotein 35-55 amino acid peptide mice. Experimental autoimmune encephalomyelitis was induced in C576146 mice with myelin oligodendrocyte glycoprotein 35-55 amino acid peptide, and parthenolide was isolated from T. porthenium. Splenocytes and peritoneal cells were obtained from experimental autoimmune encephalomyelitis -induced mice and incubated with parthenolide (1, 5, and 20 mu M). After in vitro treatment with parthenolide, supernatants were collected, and nitric oxide and cytokines were measured. The results suggested that parthenolide may regulate the activity of Th17 and Th1 cells, mainly by decreasing IL 17, TNF-alpha, and interferon gamma production. This modulation may be related to the lower levels of IL-12p40 and IL-6 after treatment with parthenolide. It was shown, for the first time, that parthenolide presents in vitro immunomodulatory effects on inflammatory mediators produced by cells from experimental autoimmune encephalomyelitis-induced mice.